Two new companion reports released today by the World Health Organization (WHO) provide the first global recommendations to help establish human genome editing as a tool
   for public health, with an emphasis on safety, effectiveness and ethics. The forward-looking new reports result from the first broad, global consultation looking at somatic, germline and heritable human genome editing. The consultation, which spanned over two years, involved hundreds of participants representing diverse perspectives
   from around the world, including scientists and researchers, patient groups, faith leaders and indigenous peoples. “Human genome editing has the potential to advance our ability to treat and cure disease, but the full impact will only be realized if we deploy it for the benefit of all people, instead of fueling more health inequity between and within countries,”
   said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. Potential benefits of human genome editing include faster and more accurate diagnosis…